Recent Advances in Immunotheragnostics: From Molecular Basis to Targeted Pharmaceutical Design 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 14778
Special Issue Editors
Interests: (radio)immunotherapy and imaging of tumors; bispecific antibodies; genetically modified immune effector cells; autoimmunity
Special Issues, Collections and Topics in MDPI journals
Interests: chimeric antigen receptors; B cell maturation antigen; biological therapy; antibody engineering; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Within the last few decades, immunotherapy has gained an increasingly important role beyond standard therapies and is thus considered the fourth pillar of anticancer therapy. However, from a clinical perspective, not only an efficient treatment but also reasonable patient selection and therapy monitoring are highly required for improved patient outcomes. Recent advances in immunotheranostics can pave the way toward precision oncology and personalized medicine. The implementation of imaging tools before, during, or after immunotherapy, especially in the case of living drugs, can help to predict and understand possible effects, as well as side effects of immunotherapy. Further, they can prospectively allow therapeutic interventions if needed. Precise and periodic target verification and assessment of molecular response to therapy can help decision making and guide appropriate patient-specific treatment.
This Special Issue aims to provide a comprehensive overview of recent advances in cancer immunotheranostics and their significance for personalized medicine. Basic and translational original or review articles submitted to this issue may address various types of immunotherapeutics ranging from small molecules, peptides, nanoparticles, nanobodies, full-size, and recombinant antibodies to cells. Authors are encouraged to address topics including but not limited to biomedical research in the field of theranostic development, target and biomarker identification, novel targeted immunotheranostics, molecular in vivo imaging, or sophisticated combinatorial approaches for immunotherapy and tumor visualization.
Prof. Dr. Michael P. Bachmann
Dr. Anja Feldmann
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotheranostics
- molecular imaging
- radioimmunotherapy
- cancer immunotherapy
- targeted therapy
- biochemical response
- image-guided therapy
- drug development
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
